Is sickle cell disease-related neurotoxicity a systemic endotheliopathy?

• Main Authors: Marta Palomo, Maribel Diaz-Ricart, Enric Carreras
• Format: Article
• Language: English
• Published: Elsevier 2020-06-01
• Series: Hematology/Oncology and Stem Cell Therapy
• Subjects: Endothelium; SCD; Inflammation; Adhesion receptors
• Online Access: http://www.sciencedirect.com/science/article/pii/S1658387620300224

The aim of the present article is to review the role of endothelial damage and dysfunction in the vaso-occlusive episodes associated with sickle cell disease (SCD). This inherited hematological disorder leads to irreversible damage of multiple organs through a wide variety of mechanisms, such as sickling of red cells, oxidative state due to ischemic-reperfusion episodes, inflammation, hypercoagulation state, and platelet activation, among others. In SCD, the endothelium arises as the key entity where most of these processes, which eventually lead to increased morbidly and mortality, interact. This review begins with the already accepted idea that organ-specific vasculopathy precedes clinical manifestation, and briefly explains one of the main triggers of vaso-occlusive episodes, the complex interplay between blood cells and the dysfunctional endothelium. Endothelial protective strategies emerge as a potential tool for the prevention of organ-specific disease in SCD. Actually, this knowledge is currently used for the development of potential pharmacologic interventions to improve the lives of SCD patients.